GreensKeeper Value Fund Q3 2026 Portfolio Activity

Impact · against what's priced in

The portfolio activity report contains no new catalysts for ICE or Visa, as the described growth and recovery trends are already embedded in their respective valuations. TVA Group shows strong momentum, though it lacks a detailed valuation baseline to determine if the earnings peak is fully priced.

V+0.00: Already priced in
The price assumes: Revenue growth of roughly 12%
The sustained double-digit growth in payment volumes and revenues simply confirms the ~12% growth rate the market already assumes as the baseline.
What V's price assumes · Sep 11

GreensKeeper Value Fund Q3 2026 Portfolio Activity

earnings▲40%
regulation
ICE
V
futures
payments
portfolio performance

Top 1 mover · tap to explore

GreensKeeper Value Fund Q3 2026 Portfolio Activity

What matters in this story

Nu Holdings Earned More Than $1 Billion in a Quarter for the First Time. Now It's Launching in the U.S.

GreensKeeper Value Fund Q3 2026 Portfolio Activity

What matters in this story

Nu Holdings Earned More Than $1 Billion in a Quarter for the First Time. Now It's Launching in the U.S.

How each ticker is affected

Track these names every morning.

Amkor Technology: Nvidia's $3 Billion Vote Of Confidence Lands On A De-Rated Stock

Dr. Reddy's Laboratories: 3 Key Takeaways for Long-Term Investors

The Metals Company Trades at $2.65. Analysts See It at $10.

Meta Q3: Non-Recurring Charge Hit GAAP Earnings, Q4 Capex Will Jump Sharply

GreensKeeper Value Fund Q3 2026 Portfolio Activity

What matters in this story

Next reads from the same story arc

Nu Holdings Earned More Than $1 Billion in a Quarter for the First Time. Now It's Launching in the U.S.

GreensKeeper Value Fund Q3 2026 Portfolio Activity

What matters in this story

Next reads from the same story arc

Nu Holdings Earned More Than $1 Billion in a Quarter for the First Time. Now It's Launching in the U.S.

How each ticker is affected

Track these names every morning.

Amkor Technology: Nvidia's $3 Billion Vote Of Confidence Lands On A De-Rated Stock

Dr. Reddy's Laboratories: 3 Key Takeaways for Long-Term Investors

The Metals Company Trades at $2.65. Analysts See It at $10.

Meta Q3: Non-Recurring Charge Hit GAAP Earnings, Q4 Capex Will Jump Sharply